FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30173611000001105: Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94053901000001116 Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94054001000001118 Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Is a Empagliflozin 5mg / Metformin 850mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has AMP Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has specific active ingredient Empagliflozin true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start